Activ Surgical
Boston, US · Founded 2017 · Delaware corporation · 41 employees on LinkedIn · 15 known investors
Find your way into Activ Surgical
162 people in our graph share verified history with the Activ Surgical team — schools, employers, funds. One of them is your warm intro.
Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye. Its first product, ActivSight Intelligent Light, provides real-time dye-free perfusion and ICG imaging and is compatible with minimally invasive surgery systems.
Also known as ActivSurgical
Founders & leadership
Activ Surgical was founded in 2017 by Peter Kim.
Board
Investors · 15
Reported raises · per SEC filings
Form D private placements$86.6M disclosed across 6 rounds · 2017–2022
▶$14.6MraisedApr 2022 · 18 investors · Other Health CareRule 506(b)
- PETER KIMExecutive Officer, Director
- TODD USENExecutive Officer, Director
- WILL COWENDirector
- PAUL MEISTERDirector
- BABAK YAZDANIDirector
- AMEENA EL-BIBANYDirector
- ASHOK KRISHNAMURTHIDirector
- TOM CALEFExecutive Officer
- EMILY CASEYDirector
- HEATHER MANNILAExecutive Officer
- Offering amount
- $14.6M
- Amount sold
- $14.6M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.6MraisedJul 2021 · 16 investors · Other Health CareRule 506(b)
- HEATHER MANNILAExecutive Officer
- EMILY CASEYDirector
- ASHOK KRISHNAMURTHIDirector
- PETER KIMExecutive Officer, Director
- BABAK YAZDANIDirector
- TODD USENExecutive Officer, Director
- WILL COWENDirector
- PAUL MEISTERDirector
- TOM CALEFExecutive Officer
- AMEENA EL-BIBANYDirector
- Offering amount
- $42.6M
- Amount sold
- $40.6M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedJul 2020 · 10 investors · Other Health CareRule 506(b)
- Ameena El-BibanyDirector
- Ashok KrishnamurthiDirector
- Tom CalefExecutive Officer
- Paul MeisterDirector
- Will CowenDirector
- Emily CaseyDirector
- Michael RuehlmanExecutive Officer
- Sub DattaExecutive Officer
- Peter KimExecutive Officer, Director
- Todd UsenExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.9MraisedJul 2019 · 8 investors · Other Health CareRule 506(b)
- Michael RuehlmanExecutive Officer
- Emily CaseyDirector
- Ashok KrishnamurthiDirector
- David WellsDirector
- Peter KimDirector
- Todd UsenExecutive Officer, Director
- Offering amount
- $18.5M
- Amount sold
- $12.9M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedApr 2018 · 4 investors · Other Health CareRule 506(b)
- Seth TeicherDirector
- Peter KimDirector
- David H. WellsExecutive Officer, Director
- Offering amount
- $4.5M
- Amount sold
- $2M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.5MraisedJun 2017 · 1 investors · Other Health CareRule 506(b)
- David H WellsExecutive Officer, Director
- Peter C.W. KimDirector
- Seth TeicherDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Proceeds to insiders
- $129K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Activ Surgical develops intraoperative surgical intelligence technology intended to give surgeons real-time visual insights during procedures. Its stated aim is to let surgeons view critical physiological structures and functions that cannot be seen with the naked eye, and to extend such imaging insights across surgical systems by visually mapping the surgical field.
The company's first commercial product, ActivSight Intelligent Light, is powered by its ActivEdge platform. ActivSight lets surgeons switch between two imaging modes with a button press: dye-free ActivPerfusion and ActivICG. The company describes the product as compatible with minimally invasive surgery (MIS) systems and as providing real-time data during surgery. The ActivEdge platform combines augmented reality, artificial intelligence, machine learning and sensing-based technologies, and is positioned as the foundation for the company's broader surgical visualization roadmap.
Activ Surgical frames its market opportunity around preventable medical error, citing figures such as 400,000+ annual U.S. deaths from avoidable complications, 26% of all medical errors being preventable surgical errors, and more than $36 billion in global cost from preventable medical errors.
Traction
The company reports clinical and commercial milestones including CE Mark approval for ActivSight Intelligent Light, a completed first international procedure with the device, and clinical study results in colorectal surgery presented at the ASCRS Annual Scientific Meeting.
Latest developments
Recent announcements include CE Mark approval for ActivSight Intelligent Light, completion of the first international procedure using ActivSight, presentation of colorectal study findings at the ASCRS Annual Scientific Meeting, and an emerging technology presentation abstract at EAES 2023.
▸Full profile — market position, technology, go-to-market, geography
Market position
Activ Surgical positions itself as an intraoperative surgical intelligence provider whose imaging insights are designed to be added to existing minimally invasive surgery systems rather than requiring a dedicated surgical platform, with the stated goal of extending gold-standard visualization insights to all surgical systems.
Technology
The ActivEdge platform integrates augmented reality, artificial intelligence, machine learning and sensing-based technologies to visually map the surgical field and surface physiological structures and functions not visible to the naked eye. The first product built on the platform, ActivSight Intelligent Light, delivers real-time intraoperative data and supports two selectable imaging modes: dye-free perfusion imaging (ActivPerfusion) and indocyanine green fluorescence imaging (ActivICG), with compatibility for minimally invasive surgery systems.
Go-to-market
Surgeons and surgical teams performing minimally invasive procedures, including colorectal surgery, where the company has conducted clinical study work.
Geography
Headquartered at 27-43 Wormwood Street, Suite 400, Boston, Massachusetts, United States, with a U.S. contact line. The company has obtained CE Mark approval for ActivSight, supporting European market access, and has announced completion of its first international procedure using the product.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 7
by search overlap
Companies competing with Activ Surgical for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 3
launches, deals, and filingsThe company announced completion of the first international procedure performed using its ActivSight Intelligent Light.
Activ Surgical presented findings from a colorectal study using ActivSight Intelligent Light at the ASCRS Annual Scientific Meeting; an emerging technology presentation abstract was also featured at EAES 2023.
Activ Surgical announced it secured CE Mark approval for its ActivSight Intelligent Light product.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureIn the news
▸Research sources · 1
primary sources listed
- Activ Surgicalactivsurgical.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Activ Surgical do?
- Activ Surgical builds intraoperative surgical intelligence hardware and software that shows surgeons structures invisible to the eye.
- Who founded Activ Surgical?
- Activ Surgical was founded by Peter Kim in 2017.
- Who are Activ Surgical's investors?
- Activ Surgical's investors include Reimagined Ventures, Alumni Ventures, Artis Ventures, Basecamp Fund, Castor Ventures (an Alumni Ventures Fund), Cota Capital, Dns Capital, GreatPoint Ventures and 7 more.
- How much funding has Activ Surgical raised?
- Activ Surgical has disclosed $86.6M raised across 6 rounds.
- Where is Activ Surgical headquartered?
- Activ Surgical is headquartered in Boston, US.